You just read:

Oxford BioTherapeutics Licenses BioWa's POTELLIGENT(R) Technology for the Research and Development of its Therapeutic Antibodies in Cancer

News provided by

Oxford BioTherapeutics

Apr 06, 2011, 06:00 ET